Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating activities:
Net earnings	$ 619	$ 629
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	157	133
Stock-based compensation	52	37
Deferred income taxes	(21)	5
Goodwill, trademark and other asset impairments	329	0
Other	(53)	26
Changes in:
Receivables, net	46	(102)
Inventories, net	(220)	50
Prepaid expenses and other current assets	(29)	(6)
Accounts payable and accrued liabilities	94	53
Operating lease right-of-use assets and liabilities, net	(1)	7
Income taxes payable / prepaid	(80)	(26)
Net cash provided by operations	893	806
Investing activities:
Capital expenditures	(232)	(158)
Businesses acquired, net of cash acquired	(85)	0
Other	(24)	13
Net cash used for investing activities	(341)	(145)
Financing activities:
Notes and loans payable, net	0	234
Treasury stock purchased	(605)	(225)
Cash dividends paid to Clorox stockholders	(420)	(399)
Cash dividends paid to noncontrolling interests	(18)	0
Issuance of common stock for employee stock plans and other	99	129
Net cash used for financing activities	(944)	(261)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	10	(8)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(382)	392
Cash, cash equivalents, and restricted cash:
Beginning of period	879	113
End of period	$ 497	$ 505